TGD came up in my Deep Value screeners as one of the highest ranked companies in the screener, so I took a look to see what they were about. Timmins Gold Corp is obviously a gold mining company, so right away I knew their success or demise was closely tied to whatever the price of gold did. Before going into the fundamentals, let's take a look at the charts....
I will buy this above 64 with sl of 60 with a potential target of 94-130.After decline for months, stock has given breakout, pulled back and then given a candlestick buy signal
TRIANGULAR BREAKOUT. BULLS AND THE BEARS ARE STUCK LOOKING TO LONG THE BREAKOUT HERE. SMALL CAP STOCK. BREAKOUT IS LOOKING BULLISH BUT IF IT DOES BREAK DOWNWARDS CAN ALWAYS SHORT
Small Caps (IWM) - It seems IWM is having a hard time making it back above the black line (13-year trendline) this week and closed right below the purple line (since-2009 trendline) today. Note that in early January IWM broke below the purple line for the first time and dropped a lot.
Simply a very clean ABCD pattern forming, get long in C or above the neckline at D.
Former runner after the CEO announced that this year will be a good year of revenue and reform. He also mentioned, how ICLD has reduced debt into the close of 2015. The CEO here is hyping the shareholders after this junk stock has been crushed quarter after quarter. This can spike again and there is dip buying volume as i point out. TradingView doesn't receive...
Harvard Apparatus Regentive Technology is a bioscience company working on more natural heart valve replacements and other pretty cool biotech stuff. However my interest is because the way they are ramping up for another go after moving from $0.60 to $3.25 in less than a month. This is shaping up to be your typical "head and shoulders" scenario. HART's 1day MACD...
Gigamon stock broke above its Keltner Channel today which suggests very strong buying power. The volume 50 day MA has been moving higher as Gigamon stock has moved higher. That indicates more and more buyers are stepping in. Gigamon stock is a continuation layout play where we are wagering that the strong uptrend will continue. Source: www.guerillastocktrading.com
Investors are expecting big things in MiMedx which is why growth is not cheap. The forward P/E is 33.6, the PEG is 6.35, and the P/S is 7.26. Still, revenue growth over the last 4 years has been shocking. In 2011, revenue was $7.8 million. In 2014, revenue had grown to $118.2 million. That’s more than a +1,500% increase in revenue over the last 4 years. The...
Definitely an optimistic outlook , but we will see.
Continuing coverage of ACRX this week, we saw ACRX pullback with the market as a whole early this morning. ACRX broke right through support at the .236 retrace, but found support at yesterdays congested zone at the .382 retrace. Uptrend remains in place. $9 remains 1st target. Stop now at 7.70.
This is the ratio RU2000 (IWM) / S&P100 (OEF) Being the GENERAL equity market trend mainly lead by small caps, the ratio IWM / OEF should test the channel before the uptrend resumes. Which means, the the denominator should perform better than the numerator for the next few months at least.